Specifically, as a key active peptide of the renin-angiotensin system, binding of angiotensin II to the angiotensin II type one (AT1) receptor promotes cell proliferation, angiogenesis, and inflammation, increasing the risk of cancer [49]. The gene discussed is REN; the disease is cancer.